Episode 501: MJA Podcasts 2022 Episode 43: New hope for resistant hypertension, with Prof Markus Schlaich
Vol 217, Issue 11: 28 November 2022. Professor Markus Schlaich is Director of the Dobney Hyperten...
The Medical Journal of Australia · theMJA
Audio is streamed directly from the publisher (themja.podomatic.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Vol 217, Issue 11: 28 November 2022. Professor Markus Schlaich is Director of the Dobney Hypertension Centre in Perth, and Dobney Chair of Clinical Research at the University of Western Australia. His recently published research on dual endothelin antagonist aprocitentin for resistant hypertension can be found at The Lancet. His op-ed for InSight+ is free to access and can be found here. With MJA news and online editor Cate Swannell.